A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancerGayle Jameson, Nicholas J. Robert, Emanuel F. Petricoin et al.|Breast Cancer Research and Treatment|2014Cited by 82
Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World DataCeline Yeh, Susan E. Bates, Mengxi Zhou et al.|The Oncologist|2022Cited by 11
Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinomaKuntal Halder, Haiyong Han, Susan Tsai et al.|British Journal of Cancer|2025Cited by 2